🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Location
Johns Hopkins
Start Date
2020-09-25
Trial ID
NCT04375228
Treatments Being Tested
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
University of Arizona Cancer Center - North Campus /ID# 16721
Start Date
2009-07-21
Trial ID
NCT00788684
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
The purpose of this clinical trial is to evaluate efficacy and safety of ti...
Status
Recruiting
Location
Mayo Clinic Cancer Center
Start Date
2026-06-12
Trial ID
NCT07104032
Treatments Being Tested
That anti-TNF therapy and rituximab therapy are equally effective in treati...
Status
Completed
Location
NHS Fife
Start Date
2010-04
Trial ID
NCT01021735
Treatments Being Tested
This study is a multicentric trial evaluating the efficacy of the RFM regim...
Status
Completed
Location
Service de médecine D - Maladies du Sang CHU Angers
Start Date
2001-04
Trial ID
NCT00169208
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720